SB241 - Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
Texas - 88th Legislature Regular Session
Introduced byCharles Perry, James Talarico
Last updated over 1 year ago
2 Co-Sponsors
STATUS
Passed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity nowError
You must be a resident or registered voter in this state.